Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Fontana

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
Revue Medicale Suisse|July 14, 2017
[News in Angiology and Hemostasis]Pierre Fontana, Helia Robert-Ebadi, Marc Blondon, et al.
European Journal of Anaesthesiology|January 16, 2018
Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit modelFanny Bonhomme, Thomas Lecompte, Charles M Samama, et al.
Swiss Medical Weekly|March 11, 2016
Direct oral anticoagulants: a guide for daily practicePierre Fontana, Helia Robert-Ebadi, Henri Bounameaux, et al.
Platelets|April 24, 2015
Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo studyFanny Bonhomme, Robert Bonvini, Jean-Luc Reny, et al.
Journal of Thrombosis and Haemostasis : JTH|April 19, 2025
Different D-dimer assays with age-adjusted cutoff to exclude pulmonary embolism: secondary analysis of ADJUST-PE studyHelia Robert-Ebadi, Christophe Combescure, Oana Bulla, et al.
Current Drug Metabolism|July 17, 2015
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-ReviewYassine Bouatou, Caroline Flora Samer, Pierre Fontana, et al.
Clinical Pharmacokinetics|June 29, 2019
Towards Personalized Antithrombotic Treatments: Focus on P2Y<sub>12</sub> Inhibitors and Direct Oral AnticoagulantsJean Terrier, Youssef Daali, Pierre Fontana, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 5, 2023
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleedingAlessandro Casini, Michal Yaron, Alexander Couzens, et al.
Journal of Proteomics|September 22, 2018
A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot studyFrancesco Finamore, Jean-Luc Reny, Sarah Malacarne, et al.
Hamostaseologie|May 7, 2026
An Unusual Association Between Acquired Hemophilia A and Type 2 Autoimmune PancreatitisMichael Iarossi, Cuong An Do, Jean-Louis Frossard, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Revue Medicale Suisse|July 14, 2017
[News in Angiology and Hemostasis]Pierre Fontana, Helia Robert-Ebadi, Marc Blondon, et al.
European Journal of Anaesthesiology|January 16, 2018
Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit modelFanny Bonhomme, Thomas Lecompte, Charles M Samama, et al.
Swiss Medical Weekly|March 11, 2016
Direct oral anticoagulants: a guide for daily practicePierre Fontana, Helia Robert-Ebadi, Henri Bounameaux, et al.
Platelets|April 24, 2015
Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo studyFanny Bonhomme, Robert Bonvini, Jean-Luc Reny, et al.
Journal of Thrombosis and Haemostasis : JTH|April 19, 2025
Different D-dimer assays with age-adjusted cutoff to exclude pulmonary embolism: secondary analysis of ADJUST-PE studyHelia Robert-Ebadi, Christophe Combescure, Oana Bulla, et al.
Current Drug Metabolism|July 17, 2015
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-ReviewYassine Bouatou, Caroline Flora Samer, Pierre Fontana, et al.
Clinical Pharmacokinetics|June 29, 2019
Towards Personalized Antithrombotic Treatments: Focus on P2Y<sub>12</sub> Inhibitors and Direct Oral AnticoagulantsJean Terrier, Youssef Daali, Pierre Fontana, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 5, 2023
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleedingAlessandro Casini, Michal Yaron, Alexander Couzens, et al.
Journal of Proteomics|September 22, 2018
A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot studyFrancesco Finamore, Jean-Luc Reny, Sarah Malacarne, et al.
Hamostaseologie|May 7, 2026
An Unusual Association Between Acquired Hemophilia A and Type 2 Autoimmune PancreatitisMichael Iarossi, Cuong An Do, Jean-Louis Frossard, et al.
Pageof 19